Barr Tries To Cut Generic Market By Entering It

Law360, New York (September 8, 2006, 12:00 AM EDT) -- Barr Pharmaceuticals Inc. is launching a generic of a subsidiary’s birth control drug, Seasonale, after a rival won U.S. Food and Drug Administration approval of a generic equivalent.

Watson Pharmaceuticals filed an Abbreviated New Drug Application for levonorgestrel/ethinyl estradioal tablets following expiration of Barr’s product exclusivity earlier this month.

"While issues related to our application with the Patent and Trademark Office to reissue the patent covering Seasonale are being resolved, we will take those steps appropriate to defend our interests in this proprietary product," said Bruce...
To view the full article, register now.